Cas:352438-73-4 5-(hydroxymethyl-d2)uracil-6-d1 manufacturer & supplier

We serve Chemical Name:5-(hydroxymethyl-d2)uracil-6-d1 CAS:352438-73-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-(hydroxymethyl-d2)uracil-6-d1

Chemical Name:5-(hydroxymethyl-d2)uracil-6-d1
CAS.NO:352438-73-4
Synonyms:5-uracil-6-d1;5-[Hydroxy(H)methyl]-2,4(1H,3H)-(6-H)pyrimidinedione;5-[Hydroxy(H)methyl](6-H)pyrimidine-2,4(1H,3H)-dione;2,4(1H,3H)-Pyrimidinedione-6-d, 5-(hydroxymethyl-d)-
Molecular Formula:C5H3D3N2O3
Molecular Weight:145.131
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.4±0.1 g/cm3
Index of Refraction:1.528
PSA:85.95000
Exact Mass:145.056671
LogP:-0.50

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-uracil-6-d1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4(1H,3H)-Pyrimidinedione-6-d, 5-(hydroxymethyl-d)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-uracil-6-d1 Use and application,5-[Hydroxy(H)methyl](6-H)pyrimidine-2,4(1H,3H)-dione technical grade,usp/ep/jp grade.


Related News: The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 5-(hydroxymethyl-d2)uracil-6-d1 manufacturer Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies. 5-(hydroxymethyl-d2)uracil-6-d1 supplier Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies. 5-(hydroxymethyl-d2)uracil-6-d1 vendor Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). 5-(hydroxymethyl-d2)uracil-6-d1 factory But it has been barred from that body as Beijing has increased pressure on Taiwan under President Tsai Ing-wen, who is skeptical about closer ties with China.